Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 1, 2007, Pages 8-10

  Van Wyck, David ^a   Eckardt, Kai Uwe ^b   Uhlig, Katrin ^c   Rocco, Michael ^d   Levin, Adeera ^e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; NEPHROLOGY; NOTE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; STANDARD;

EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE;

EID: 34247383311     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02840806     Document Type: Article

References (13)

1. Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Star R, Toto R, Eknoyan G: Association of achieved dialysis dose with mortality in the hemodialysis study: An example of "dose-targeting bias." J Am Soc Nephrol 16: 3371-3380, 2005
2. Manns B, Owen WF Jr, Winkelmayer WC, Devereaux PJ, Tonelli M: Surrogate markers in clinical studies: Problems solved or created? Am J Kidney Dis 48: 159-166, 2006
3. Fishbane S: EPO adjuvant treatments: A need for more evidence. Am J Kidney Dis 47: 683-685, 2006
4. NKF-DOQI clinical practice guidelines. National Kidney Foundation. Am J Kidney Dis 30: S6-S11, 1997
5. Steinberg EP, Eknoyan G, Levin NW, Eschbach JW, Golper TA, Owen WF, Schwab S: Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: Description, findings, and implications. Am J Kidney Dis 36: 1-11, 2000
6. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47: S11-S145, 2006
7. Cook DJ, Mulrow CD, Haynes RB: Systematic reviews: Synthesis of best evidence for clinical decisions. Ann Intern Med 126: 376-380, 1997
8. Uhlig K, MacLeod A, Craig A, Lau J, Levey AS, Levin A, Moist L, Steinberg E, Walker R, Wanner C, Lameire N, Eknoyan G: Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int September 27, 2006 [epub ahead of print]
9. Uhlig K, Balk EM, Lau J, Levey AS: Clinical practice guidelines in nephrology: For worse or for better. Nephrol Dial Transplant 21: 1145-1153, 2006
10. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H: The burden of kidney disease: Improving global outcomes. Kidney Int 66: 1310-1314, 2004
11. Lameire N, Eknoyan G, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H: A new initiative in nephrology: 'Kidney Disease: Improving Global Outcomes.' Contrib Nephrol 149: 90-99, 2005
12. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30: S192-S240, 1997
13. Collins AJ, Roberts TL, St Peter WL, Chen SC, Ebben J, Constantini E: United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. Am J Kidney Dis 39: 784-795, 2002